Bridion 200 MG/2 ML vial 2ML
Ended Awarded
- Contract number
- SPE2DB25FBCE1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,844
Award facts
- Contract value 100% obligated
- $15,843.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Bridion (sugammadex) 200 mg/2 mL vials totaling $15,843.78. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 18, 2025, reflecting the time-sensitive nature of federal medical supply chains supporting military healthcare operations.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated capability to meet competitive federal procurement requirements through its extensive portfolio of deliveries to the Defense Logistics Agency and related military healthcare systems. As a prime vendor under the DLA's pharmaceutical support framework, the company supplies a comprehensive range of pharmaceutical products and medical commodities to support military personnel and veteran healthcare needs. This delivery order for Bridion, a neuromuscular blocking agent reversal agent used in anesthesia management, exemplifies the specialized pharmaceutical support AmerisourceBergen provides across multiple therapeutic domains to federal healthcare customers.
Quick answers
Who was awarded contract SPE2DB25FBCE1?
SPE2DB25FBCE1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 17, 2025.
How much is contract SPE2DB25FBCE1 worth?
The government has obligated $15,844 on SPE2DB25FBCE1.
Is contract SPE2DB25FBCE1 an order under another contract?
Yes. SPE2DB25FBCE1 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBCE1 competed?
The extent of competition for SPE2DB25FBCE1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award